Histopathologic findings associated with APOL1 risk variants in chronic kidney disease

被引:48
|
作者
Larsen, Christopher P. [1 ]
Beggs, Marjorie L. [1 ]
Saeed, Mohammad [1 ]
Ambruzs, Josephine M. [1 ]
Cossey, L. Nicholas [1 ]
Messias, Nidia C. [1 ]
Walker, Patrick D. [1 ]
Freedman, Barry I. [2 ]
机构
[1] Nephropath, Little Rock, AR 72211 USA
[2] Wake Forest Sch Med, Winston Salem, NC USA
关键词
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; STAGE RENAL-DISEASE; AFRICAN-AMERICANS; HYPERTENSIVE NEPHROSCLEROSIS; CLASSIFICATION; MORPHOLOGY; HIV;
D O I
10.1038/modpathol.2014.92
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The effects of nephropathy risk variants in the apolipoprotein L1 gene (APOL1) on renal histopathology in African Americans with arterionephrosclerosis or putative 'hypertension-associated' nephropathy are unknown. APOL1 genotype-phenotype correlations were performed in a blinded manner from renal biopsies in 196 self-reported African Americans with arterionephrosclerosis on kidney biopsy at a large national nephropathology practice. Subjects had chronic kidney disease without nephrotic syndrome. A discovery analysis compared histopathologic changes in the glomerular and tubulointerstitial compartments in 58 subjects with 2 versus 56 subjects with 0 APOL1 risk variants. Validation was performed in biopsies from 82 additional subjects with 0, 1, and 2 risk variants. Two risk variant versus zero risk variant group genotype associations and subphenotypes were assessed by chi(2) analyses. ANOVA compared means of continuous variables. In discovery analyses, significantly less obsolescent glomerulosclerosis, more (solidified and disappearing) glomerulosclerosis, more thyroidization-type tubular atrophy, and more microcystic tubular dilatation were seen in patients with two versus zero APOL1 risk alleles. Greater degrees of arteriosclerosis were present in those with zero risk alleles. Segmental glomerulosclerosis did not differ significantly between groups. Presence of two of the following discriminatory histopathologic findings from discovery, that is, <50% obsolescent glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilatation, was specific for the presence of two APOL1 risk alleles in the validation phase. African Americans with arterionephrosclerosis who possess two APOL1 risk variants more often lack obsolescent glomerulosclerosis and have greater degrees of (solidified and disappearing) glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilation than patients with fewer than two risk variants. These findings support involvement of multiple cell types in subnephrotic forms of APOL1-associated nephropathy, particularly renal tubule cells with resultant tubulointerstitial disease.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 50 条
  • [41] A focus on the association of Apol1 with kidney disease in children
    Ekulu, Pepe M.
    Nkoy, Agathe B.
    Adebayo, Oyindamola C.
    Kazadi, Orly K.
    Aloni, Michel N.
    Arcolino, Fanny O.
    Ngiyulu, Rene M.
    Gini, Jean-Lambert E.
    Lepira, Francois B.
    van den Heuvel, Lamberthus P.
    Levtchenko, Elena N.
    PEDIATRIC NEPHROLOGY, 2021, 36 (04) : 777 - 788
  • [42] Absence of APOL1 Risk Variants Protects against HIV-Associated Nephropathy in the Ethiopian Population
    Behar, Doron M.
    Kedem, Eynat
    Rosset, Saharon
    Haileselassie, Yonas
    Tzur, Shay
    Kra-Oz, Zipi
    Wasser, Walter G.
    Shenhar, Yotam
    Shahar, Eduardo
    Hassoun, Gamal
    Maor, Carcom
    Wolday, Dawit
    Pollack, Shimon
    Skorecki, Karl
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (05) : 452 - 459
  • [43] Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease
    Hu, Chien-An A.
    Klopfer, Edward I.
    Ray, Patricio E.
    FEBS LETTERS, 2012, 586 (07) : 947 - 955
  • [44] APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy
    Kopp, Jeffrey B.
    Heymann, Jurgen
    Winkler, Cheryl A.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 514 - 519
  • [45] APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
    Bruggeman, Leslie A.
    O'Toole, John F.
    Sedor, John R.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 316 (01) : F1 - F8
  • [46] APOL1 and Kidney Disease: New Insights Leading to Novel Therapies
    Freedman, Barry I.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (01) : 9 - 11
  • [47] APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults
    Mukamal, Kenneth J.
    Tremaglio, Joseph
    Friedman, David J.
    Ix, Joachim H.
    Kuller, Lewis H.
    Tracy, Russell P.
    Pollak, Martin R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (02) : 398 - 403
  • [48] APOL1 Risk Variants and Acute Kidney Injury in Black Americans with COVID-19
    Larsen, Christopher P.
    Wickman, Terrance J.
    Braga, Juarez R.
    Matute-Trochez, Luis A.
    Hasty, Anna E.
    Buckner, Lyndsey R.
    Arthur, John M.
    Haun, Randy S.
    Velez, Juan Carlos Q.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (12): : 1790 - 1796
  • [49] APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease
    Beckerman, Pazit
    Susztak, Katalin
    TRENDS IN MOLECULAR MEDICINE, 2018, 24 (08) : 682 - 695
  • [50] MYH9 and APOL1 are both associated with sickle cell disease nephropathy
    Ashley-Koch, Allison E.
    Okocha, Emmanuel C.
    Garrett, Melanie E.
    Soldano, Karen
    De Castro, Laura M.
    Jonassaint, Jude C.
    Orringer, Eugene P.
    Eckman, James R.
    Telen, Marilyn J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (03) : 386 - 394